Reflux Esophagitis

• CLINICAL_TRIALS research · 2026-03-06
  Clinical Trial Update: A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks [NA]

  An ongoing randomized, three-arm trial compares vonaprazan 10 mg and 20 mg with esomeprazole 40 mg for healing LA Grade B or higher reflux e…

• CLINICAL_TRIALS research · 2025-09-29
  Clinical Trial Update: A Clinical Trial of Anaprazole for Treating Reflux Esophagitis. [Phase 3]

  A Phase 3 clinical trial is recruiting to evaluate Anaprazole for treating Reflux Esophagitis.

• CLINICAL_TRIALS research · 2025-04-04
  Clinical Trial Update: Role of ARMA in Selective Subset of Refractory GERD Patients. [NA]

  This clinical trial evaluated the role of ARMA in a selective subset of patients with refractory gastroesophageal reflux disease and has com…

• CLINICAL_TRIALS research · 2025-02-27
  Clinical Trial Update: A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis [Phase 3]

  A Phase III clinical trial evaluating the efficacy and safety of JP-1366 tablets for reflux esophagitis is currently recruiting.

• CLINICAL_TRIALS research · 2022-09-22
  Clinical Trial Update: Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome [NA]

  Completed clinical trial evaluating the effects of an antimicrobial mouthwash on the esophageal microbiome; results posted in 2022.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2012-02-20
  Clinical Trial Update: Analysis of GERD Symptoms Using Gastroesophageal Reflux Impact Score Questionnaire for Quality of Life

  This completed clinical trial analyzed GERD symptoms and quality of life using the GERD Impact Score questionnaire.

• CLINICAL_TRIALS research · 2008-03-19
  Clinical Trial Update: Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis [Phase 2]

  A Phase 2 study of S-Tenatoprazole-Na for erosive or ulcerative esophagitis has been suspended.